Bristol John W & Co Inc /Ny/ / NVSN
Bristol John W & Co Inc /Ny/’s Novartis AG Position
Does Bristol John W & Co Inc /Ny/ own Novartis AG (NVSN)? Yes — 561.8K shares worth $86M (+1.41% of its 13F portfolio) as of Q1 2026, down from 569.7K shares the prior filed quarter.
Position Value
$86M
Q1 2026
Shares
561.8K
% of Portfolio
+1.41%
Quarters Held
30
currently held
Position History NVSN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 561.8K | $86M | +1.41% |
| Q4 2025 | 569.7K | $79M | +1.21% |
| Q3 2025 | 581.7K | $75M | +1.18% |
| Q2 2025 | 592.3K | $72M | +1.16% |
| Q1 2025 | 593.7K | $66M | +1.13% |
| Q4 2024 | 609.7K | $59M | +0.97% |
| Q3 2024 | 623.7K | $72M | +1.15% |
| Q2 2024 | 624.9K | $67M | +1.08% |
| Q1 2024 | 638.6K | $62M | +1.05% |
| Q4 2023 | 642.8K | $65M | +1.19% |
| Q3 2023 | 675.4K | $69M | +1.36% |
| Q2 2023 | 682.5K | $69M | +1.30% |
| Q1 2023 | 687.0K | $63M | +1.30% |
| Q4 2022 | 683.2K | $62M | +1.47% |
| Q3 2022 | 679.7K | $52M | +1.29% |
| Q2 2022 | 689.9K | $58M | +1.43% |
| Q1 2022 | 708.6K | $62M | +1.23% |
| Q4 2021 | 725.5K | $63M | +1.10% |
| Q3 2021 | 734.2K | $60M | +1.12% |
| Q2 2021 | 745.3K | $68M | +1.25% |
| Q1 2021 | 751.0K | $64M | +1.31% |
| Q4 2020 | 754.7K | $71M | +1.47% |
| Q3 2020 | 755.8K | $66M | +1.49% |
| Q2 2020 | 751.6K | $66M | +1.63% |
| Q1 2020 | 768.2K | $63M | +1.97% |
| Q4 2019 | 778.1K | $74M | +1.78% |
| Q3 2019 | 785.0K | $72M | +1.85% |
| Q2 2019 | 770.9K | $70M | +1.86% |
| Q1 2019 | 779.2K | $75M | +2.06% |
| Q4 2018 | 782.9K | $67M | +2.15% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bristol John W & Co Inc /Ny/’s full portfolio or all institutional holders of NVSN.